drugset / Trial / NCT03048110
Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction
NaSingle-groupOpen-labelOther
Summary
Evaluate the effect of a probe CYP3A4 inhibitor and inducer on the pharmacokinetics of BAY1841788 (ODM-201)
Timeline
- Start
- 2017-02-15
- Primary completion
- 2017-05-04
- Completion
- 2017-07-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darolutamide | Other / unclassified | 600 mg | — |
| Subject | Itraconazole | Small molecule | 200 mg | — |
| Subject | Rifampin | Small molecule | 600 mg | — |
Indications
No indication recorded.